BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5105727)

  • 1. Intrastriatal injection of quaternary butyrophenones and oxypertine: neuroleptic effect in rats.
    Fog R; Randrup A; Pakkenberg H
    Psychopharmacologia; 1971; 19(3):224-30. PubMed ID: 5105727
    [No Abstract]   [Full Text] [Related]  

  • 2. On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
    Fog R
    Acta Neurol Scand Suppl; 1972; 50():3-66. PubMed ID: 4565013
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic action of clozapine injected into various brain areas in rats.
    Fog R
    Int Pharmacopsychiatry; 1975; 10(2):89-93. PubMed ID: 1170144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic action of quaternary chlorpromazine and related drugs injected into various brain areas in rats.
    Fog RL; Randrup A; Pakkenberg H
    Psychopharmacologia; 1968; 12(5):428-32. PubMed ID: 5749325
    [No Abstract]   [Full Text] [Related]  

  • 5. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulman FG: Mammotropic and neuroleptic effects of butyrophenones in the rat.
    Mishkinsky J; Khazen K; Givant Y; Dikstein S
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):94-105. PubMed ID: 5388566
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic and non-neuroleptic catalepsy.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1973 May; 23(5):674-83. PubMed ID: 4740210
    [No Abstract]   [Full Text] [Related]  

  • 8. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 9. 4'-Fluoro-4-(1,4,5,6-tetrahydroazepinol[4,5-b]indol-3(2H)-yl)butyrophenones.
    Hester JB; Rudzik AD; Keasling HH; Veldkamp W
    J Med Chem; 1970 Jan; 13(1):23-6. PubMed ID: 5460894
    [No Abstract]   [Full Text] [Related]  

  • 10. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
    Janssen PA; Allewijn FT
    Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of various neuroleptic drugs on shock avoidance responding in rats. 3. Amphetamine antagonism in the discriminated Sidman avoidance procedure.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 17(2):151-9. PubMed ID: 5443882
    [No Abstract]   [Full Text] [Related]  

  • 12. The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Feb; 25(2):138-46. PubMed ID: 4154850
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivatives.
    Costall B; Funderburk WH; Leonard CA; Naylor RJ
    J Pharm Pharmacol; 1978 Dec; 30(12):771-8. PubMed ID: 32242
    [No Abstract]   [Full Text] [Related]  

  • 14. On the interaction between neuroleptics and antiparkinson drugs.
    Julou L
    Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
    Honma T; Fukushima H
    Neuropharmacology; 1976 Oct; 15(10):601-7. PubMed ID: 1033478
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of various neuroleptic drugs on noise escape response in rats.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 18(3):249-59. PubMed ID: 5530581
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?
    Costall B; Naylor RJ
    Psychopharmacologia; 1973; 32(2):161-70. PubMed ID: 4796282
    [No Abstract]   [Full Text] [Related]  

  • 19. The basic pharmacology of oxypertine.
    Penn RG
    Postgrad Med J; 1972 Sep; 48(4):Suppl 4:7-11. PubMed ID: 4202024
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
    Stille G
    Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.